From owner-biophys@hgmp.mrc.ac.uk  Mon Nov 27 16:54:39 2000
Return-Path: <owner-biophys@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id C829917AF1; Mon, 27 Nov 2000 16:54:38 +0000 (GMT)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id F30A717AEE; Mon, 27 Nov 2000 16:54:36 +0000 (GMT)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 01464415D5
	for <biophys-list@hgmp.mrc.ac.uk>; Mon, 27 Nov 2000 16:54:31 +0000 (GMT)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id QAA13318
	for biophys-list@hgmp.mrc.ac.uk; Mon, 27 Nov 2000 16:54:31 GMT
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: "Ville Tuomi" <ville.tuomi@kolumbus.fi>
X-Newsgroups: bionet.biophysics
Subject: cordycepin
Date: Mon, 27 Nov 2000 18:50:57 +0200
Organization: Kolumbus Internet Services Customer
Lines: 6
Message-ID: <8vu3fc$r1j$1@news.kolumbus.fi>
X-Newsreader: Microsoft Outlook Express 4.72.3110.5
X-MimeOLE: Produced By Microsoft MimeOLE V4.72.3110.3
To: biophys@hgmp.mrc.ac.uk
Sender: owner-biophys@hgmp.mrc.ac.uk
Precedence: bulk

Biologically produced cordycepin available.
Information and pricing available on request.







.